In a mouse xenograft model carrying the BTK C481S, T474I, and L528W mutations, BGB-16673 resulted in complete tumor regression and demonstrated long-lasting antitumor activity and low metastasis rates [134]. The gene discussed is BTK; the disease is neoplasm.